Vetoquinol Rehabilitation Business Solution (VeRBS) expands to offer on-demand courses
FORT WORTH, TEXAS (April 1, 2025) – Vetoquinol Rehabilitation Business Solution (VeRBS) announces the expansion of its in-person program to offer on-demand courses taught by leading veterinary rehabilitation experts.
“The addition of on-demand courses broadens the opportunities for veterinary rehabilitation instruction to clinics across the country,” said Heidi Rooney, MBA, Business Solutions Development Manager, Vetoquinol USA. “VeRBS will still offer the option of hands-on training, an essential equipment package, and business planning resources. Adding an online instruction option allows clinics to go at their own pace without disrupting day-to-day work.”
The VeRBS on-demand educators include experts such as:
- Duncan Lascelles, BSc, BVSc, Ph.D., DACVS, DECVS
- Marie Bartling, DVM, CVPP, CCRT, cVMA, CAC
- Matthew Brunke, DVM, DACVSMR, CCRP, CVPP, CVA
- Bethany Frank, DVM, MS, cVMA, CCRT
These educators lead RACE-approved virtual courses in rehabilitation of the thoracic limb, pelvic limb, geriatric patient, neurologic patient, and feline patient. Plus, they provide information on conducting basic orthopedic evaluations, including veterinary support staff in rehabilitation efforts, incorporating nutraceuticals, and more! On-demand participants can earn up to 8 RACE-approved continuing education credits per person.
The program is designed for veterinary clinics exploring adding rehabilitation services as a new option, certified professionals that need refresher training, teams with underutilized equipment, and clinics looking to re-energize their rehab programs.
“What clinic doesn’t want to improve comfort, restore strength, and maintain — or even improve — range of motion for their clients?” Rooney said. “With this course, clinics can earn continuing education credits while providing direct benefits to patients.”
Practices can contact Heidi Rooney at USA_Solutions@Vetoquinol.com for more information.
About Vetoquinol USA
Headquartered in Fort Worth, Texas, Vetoquinol USA is owned by Vetoquinol S.A., an independent, family-owned French pharmaceutical company founded in 1933. Dedicated exclusively to animal health, Vetoquinol USA is focused on the development, production, and marketing of AAFCO, NASC, EPA, and FDA-regulated pharmaceutical, nutritional, and dermatological products for small and large animals.
For media requests:
For customer requests:
817-529-7500
The on-demand program has been RACE approved for 8 hours, and the hands-on lab is approved for 10 hours, of continuing education credit in jurisdictions that recognize RACE approval.
©2025 VETOQUINOL USA, Inc. VETOQUINOL is a trademark of VETOQUINOL. SOL-25-00033
Latest news

FDA Approves Extended Expiration Date for Clevor® (ropinirole ophthalmic solution)
August 2024

Press Release: Fluorescent Light Energy Enhances Post Mastectomy Wound Healing in Dogs
August 2024

UpCard®-CA1 (torsemide oral solution) is Now Available
July 2024